Image courtesy: Avalon Pharma/ LinkedIn
Saudi Arabia pharma giant Middle East Pharmaceutical Industries Company, also known as Avalon Pharma, said Sunday that it plans to sell a 30 per cent stake through an initial public offering (IPO) on the Saudi Exchange (Tadawul).
Avalon Pharma, said in a statement, that it received approval from the Capital Market Authority to offer six million shares, representing 30 per cent of the company’s…
